X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (107) 107
male (82) 82
female (77) 77
middle aged (76) 76
index medicus (72) 72
aged (69) 69
oncology (62) 62
cancer (53) 53
head (48) 48
adult (46) 46
hypopharyngeal neoplasms - pathology (46) 46
squamous cell carcinoma (41) 41
hypopharyngeal neoplasms - virology (36) 36
survival (32) 32
carcinoma, squamous cell - pathology (31) 31
tumors (29) 29
aged, 80 and over (28) 28
carcinoma, squamous cell - virology (27) 27
prognosis (26) 26
retrospective studies (25) 25
chemotherapy (24) 24
laryngeal neoplasms - virology (24) 24
neck-cancer (24) 24
research article (24) 24
laryngeal neoplasms - pathology (23) 23
surgery (23) 23
medicine (22) 22
larynx (21) 21
neck (21) 21
neoplasm staging (21) 21
patients (21) 21
human papillomavirus (20) 20
hypopharyngeal neoplasms - mortality (20) 20
hypopharyngeal neoplasms - therapy (20) 20
metastasis (20) 20
radiotherapy (20) 20
science (20) 20
squamous-cell carcinoma (20) 20
cancer therapies (19) 19
multidisciplinary sciences (19) 19
otorhinolaryngology (19) 19
carcinoma, squamous cell - genetics (18) 18
carcinoma, squamous cell - therapy (18) 18
care and treatment (18) 18
hypopharyngeal neoplasms - genetics (18) 18
hypopharynx (18) 18
papillomavirus infections (18) 18
radiation therapy (18) 18
head and neck neoplasms - virology (17) 17
hypopharyngeal neoplasms - metabolism (17) 17
oropharyngeal neoplasms - virology (17) 17
head & neck cancer (16) 16
head and neck cancer (16) 16
medical prognosis (16) 16
survival analysis (16) 16
carcinoma, squamous cell - mortality (15) 15
human-papillomavirus (15) 15
hypopharyngeal cancer (15) 15
immunohistochemistry (15) 15
otolaryngology (15) 15
squamous cell carcinoma of head and neck (15) 15
throat cancer (15) 15
carcinoma, squamous cell - metabolism (14) 14
head and neck neoplasms - pathology (14) 14
oropharyngeal cancer (14) 14
papillomaviridae - isolation & purification (14) 14
pathology (14) 14
analysis (13) 13
chemoradiotherapy (13) 13
expression (13) 13
follow-up studies (13) 13
polymerase chain reaction (13) 13
research (13) 13
risk factors (13) 13
treatment outcome (13) 13
cisplatin (12) 12
diagnosis (12) 12
hpv (12) 12
hypopharyngeal neoplasms - drug therapy (12) 12
hypopharyngeal neoplasms - surgery (12) 12
oropharyngeal neoplasms - pathology (12) 12
smoking (12) 12
cancers and neoplasms (11) 11
hypopharyngeal neoplasms - radiotherapy (11) 11
laryngeal neoplasms - mortality (11) 11
metastases (11) 11
papillomavirus infections - virology (11) 11
deoxyribonucleic acid--dna (10) 10
dna (10) 10
head and neck squamous cell carcinoma (10) 10
health aspects (10) 10
laryngeal cancer (10) 10
laryngeal neoplasms - therapy (10) 10
lymphatic metastasis (10) 10
multivariate analysis (10) 10
studies (10) 10
survival rate (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
biomarkers (9) 9
cell line, tumor (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
Purpose To compare the temporal lymph node (LN) regression and regional control (RC) after primary chemoradiation therapy/radiation therapy in human... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Abstract Aim The aim is to evaluate the impact of cisplatin dose modification on outcomes of human papillomavirus (HPV)-related (HPV+) and HPV-unrelated (HPV−)... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | THERAPY | ONCOLOGY | OROPHARYNGEAL CANCER | RADIOTHERAPY | EXPRESSION | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1845 - 1850
Purpose To report the mature data of a prospective Phase II trial designed to evaluate the efficacy of an epidermal growth factor receptor inhibitor cetuximab... 
Radiology | Hematology, Oncology and Palliative Medicine | Concurrent cetuximab | Chemoradiation | Locally advanced head and neck cancer | Concurrent chemotherapy | SURVIVAL | RANDOMIZED-TRIAL | HUMAN-PAPILLOMAVIRUS | CANCER | STAGE OROPHARYNX CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | GROWTH-FACTOR RECEPTOR | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prospective Studies | Follow-Up Studies | Area Under Curve | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Oropharyngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Chemoradiotherapy - methods | ErbB Receptors - antagonists & inhibitors | Drug Administration Schedule | Nasopharyngeal Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Paclitaxel - adverse effects | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Remission Induction | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Laryngeal Neoplasms - mortality | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Medical colleges | Care and treatment | Squamous cell carcinoma | Radiation | Clinical trials | Radiotherapy | Antineoplastic agents | Antimitotic agents | Epidermal growth factor | Nuclear radiation | Analysis | Paclitaxel | Cancer | Index Medicus | GROWTH FACTORS | HEAD | PATIENTS | DERMATITIS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | NECK | RADIOTHERAPY | RECEPTORS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 5, pp. 934 - 941
Purpose We investigated the efficacy and safety of weekly low-dose docetaxel and cisplatin therapy concurrent with conventionally fractionated radiation in... 
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | SURVIVAL | ONCOLOGY | OROPHARYNGEAL CANCER | CHEMORADIOTHERAPY | LOCALLY ADVANCED HEAD | TOXICITY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | MUTATIONS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | DNA, Viral - isolation & purification | Oropharyngeal Neoplasms - mortality | Salvage Therapy | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Papillomaviridae - genetics | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Organ Sparing Treatments - methods | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Adult | Female | Chemoradiotherapy - methods | Drug Administration Schedule | Docetaxel | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Survival Rate | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Stomatitis - etiology | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Taxoids - administration & dosage | Laryngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Squamous cell carcinoma | College teachers | Cisplatin | Radiation | HUMAN POPULATIONS | HEAD | PATIENTS | SAFETY | FAILURES | METASTASES | TUBES | RADIATION DOSES | KIDNEYS | DNA | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | FEEDING | NECK
Journal Article
Journal Article
Journal Article
Oral Oncology, ISSN 1368-8375, 2012, Volume 49, Issue 1, pp. 9 - 14
Summary Objectives Patients with a head and neck squamous cell carcinoma (HNSCC) carry a high risk of second primary cancer (SPC). In recent years, a rise in... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Registries | Multivariate analysis | Head and neck neoplasms | Second primary | Risk assessment | Neoplasms | PRIMARY TUMORS | SMOKING | PREVALENCE | TOBACCO | CHILDHOOD-CANCER | ALCOHOL | ONCOLOGY | PREDICTORS | DENTISTRY, ORAL SURGERY & MEDICINE | POOLED ANALYSIS | Head and Neck Neoplasms - virology | Age Factors | Follow-Up Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Hypopharyngeal Neoplasms - epidemiology | Male | Alphapapillomavirus - isolation & purification | Esophageal Neoplasms - epidemiology | Incidence | Head and Neck Neoplasms - epidemiology | Female | France - epidemiology | Risk Assessment | Carcinoma, Squamous Cell - epidemiology | Papillomavirus Infections - epidemiology | Laryngeal Neoplasms - epidemiology | Radiotherapy - trends | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Confounding Factors (Epidemiology) | Lung Neoplasms - epidemiology | Alcohol Drinking - epidemiology | Smoking - epidemiology | Sex Factors | Aged | Population Surveillance | Cohort Studies | Cancer patients | Squamous cell carcinoma | Care and treatment | Nuclear radiation | Substance abuse | Universities and colleges | Radiotherapy | Health aspects | Papillomavirus infections | Risk factors | Public health
Journal Article
Cancer Epidemiology, ISSN 1877-7821, 2014, Volume 39, Issue 1, pp. 37 - 41
Highlights • The significance of HPV in the etiology of non-oropharyngeal head and neck cancers is uncertain. • We analyzed the possible association of HPV... 
Hematology, Oncology and Palliative Medicine | Internal Medicine | Hypopharynx | Immunohistochemistry | Squamous cell carcinoma | Human papillomavirus | Larynx | In situ hybridization | PCR | SURVIVAL | HEAD | ALGORITHM | CANCER | HPV | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ONCOLOGY | NECK | Head and Neck Neoplasms - virology | Prevalence | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Hypopharyngeal Neoplasms - epidemiology | Male | Papillomaviridae - genetics | Human papillomavirus 16 - isolation & purification | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - epidemiology | Aged, 80 and over | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Retrospective Studies | Carcinoma, Squamous Cell - epidemiology | Papillomavirus Infections - epidemiology | Repressor Proteins - genetics | Genotype | Laryngeal Neoplasms - epidemiology | Papillomaviridae - isolation & purification | Spain - epidemiology | Aged | DNA, Viral - genetics | Laryngeal Neoplasms - virology | Development and progression | Care and treatment | Diagnosis | Papillomavirus infections | Prevalence studies (Epidemiology) | Data analysis | Laboratories | Cloning | Editing | Infections | Proteins | Tobacco | Algorithms | Quality control | Cervical cancer | Deoxyribonucleic acid--DNA | Smoking
Journal Article
Acta Oto-Laryngologica, ISSN 0001-6489, 10/2014, Volume 134, Issue 10, pp. 1062 - 1070
Journal Article
American Journal of Otolaryngology--Head and Neck Medicine and Surgery, ISSN 0196-0709, 2016, Volume 38, Issue 1, pp. 31 - 37
Journal Article
American Journal of Otolaryngology--Head and Neck Medicine and Surgery, ISSN 0196-0709, 2014, Volume 35, Issue 1, pp. 19 - 24
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 4/2009, Volume 135, Issue 4, pp. 559 - 566
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e78718
Background: High-risk human papillomavirus (HPV) is an oncogenic virus that causes oropharyngeal cancers, and it has a favorable outcome after the treatment.... 
PRESERVATION | SURGERY | HEAD | MULTIDISCIPLINARY SCIENCES | POSTOPERATIVE RADIOTHERAPY | OROPHARYNGEAL CANCER | SQUAMOUS-CELL CARCINOMA | HUMAN-PAPILLOMAVIRUS | NECK | EXPRESSION | Follow-Up Studies | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Hypopharyngeal Neoplasms - mortality | Papillomavirus Infections - therapy | Papillomavirus Infections - pathology | Carcinoma, Squamous Cell - mortality | Adult | Female | Papillomavirus Infections - virology | Risk Factors | Carcinoma, Squamous Cell - therapy | Survival Rate | Papillomavirus Infections - mortality | Hypopharyngeal Neoplasms - therapy | Alphapapillomavirus - metabolism | Disease-Free Survival | Hypopharyngeal Neoplasms - metabolism | Papillomavirus Infections - metabolism | Hypopharyngeal Neoplasms - pathology | Aged | Medical research | Care and treatment | Squamous cell carcinoma | Adjuvant treatment | Medicine, Experimental | Development and progression | Papillomavirus infections | Health aspects | Cancer | Radiation | Otolaryngology | Viruses | Infections | Metastasis | Hybridization | Cancer therapies | Risk factors | Human papillomavirus | Etiology | Sinus | Oropharyngeal cancer | Surgery | Cell cycle | Dissection | Lymphatic system | Medical instruments | Health risks | Radiation therapy | Patients | Survival | Pharynx | Medicine | Pathology | Medical prognosis | Biomarkers | Head & neck cancer | Smoking
Journal Article